Evidence map›Paper›PMID 37917107›Full record

ArticleTissue engineering. Part A2024

Bioreactor Design for Culturing Vascularized Engineered Tissue in Flow Conditions.

Dora Evelyn Ibarra, Maggie E Jewett, Dillon K Jarrell, Armando Pinales, Mitchell C VeDepo, Jeffrey G Jacot

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tissue engineering. Part A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Early Atrial Remodeling Drives Arrhythmia in Fabry Disease.Circulation. Arrhythmia and electrophysiology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dora Evelyn IbarraDepartment of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Maggie E JewettDepartment of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Dillon K JarrellDepartment of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Armando PinalesIndependent Researcher, Palo Alto, California, USA.
Mitchell C VeDepoDepartment of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Jeffrey G JacotDepartment of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
University of Colorado Anschutz Medical Campus · USUniversity of Dayton · US

Funding

PRE-VASCULARIZED AND DEGRADABLE PATCHES FOR CORRECTION OF CONGENITAL HEART DEFECTSR01HL130436 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI JACOT, JEFFREY G · 2016 to 2020
$2.0M
A Translational Bioreactor for the Construction of Off-the-Shelf, Patient-Specific Heart Tissue for the Permanent Correction of Congenital Heart DefectsF31HL154606 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI JARRELL, DILLON K · 2020 to 2021
$47k
NHLBI NIH HHS F31 HL154606NHLBI NIH HHS R01 HL130436
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BioreactorsMyocytes, CardiacTissue EngineeringTissue ScaffoldsHumansHuman Umbilical Vein Endothelial CellsInduced Pluripotent Stem Cellsbioreactorelectrospinningshear stressvascularization

Identifiers

PMID37917107
PMCPMC12918702
OpenAlexW4388233820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.